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Eimeria is a genus of protozoa within the Apicomplexa, a phylum that includes Plasmodium 
species (which cause malaria) and Toxoplasma gondii (which cause foetal abnormalities and 
encephalitis), and many other species of parasites. Eimeria belongs to the subclass Coccidia, 
and a defining characteristic of this group is their transmission from host to host via oocysts 
that contaminate food and water. The resilient oocyst wall protects the parasites as they are 
excreted in the host’s faeces and in the outside world, allowing them to survive for several 
months between hosts. It is formed from the contents of specialised organelles - wall 
forming bodies - found in the macro gametocyte stage of the parasites.
Two proteins, EmGam56 and EmGam82, from the wall forming bodies of Eimeria maxima 
have been studied intensively in recent years (see Belli et al, 2006). Both are processed 
and/or degraded into smaller tyrosine-rich polypeptides (from 8 to 33 kDa) and incorporated 
into the oocyst wall. The tyrosine richness of these proteins and the presence of dityrosine in 
the oocyst wall has led to the proposal that dityrosine cross-linking of these proteins forms a 
matrix that is crucial component for oocyst wall formation (Belli et al., 2006). The aims of 
this thesis are to:
[1] deduce the biochemical composition of the oocyst walls using gas chromatography 
(GC) and mass spectrometry (MS);
[2] determine the structural features of EmGam56 using bioinformatics, circular 
dichroism (CD), and one-dimensional nuclear magnetic resonance (1D-NMR);
[3] demonstrate that peroxidase-catalysed dityrosine crosslinks can be induced to form 
between truncated forms of EmGam56.
GC and MS revealed that the Eimeria oocyst wall is composed mainly of proteins (>90%) 
with small amount of lipids (1.4-7.6%) and carbohydrates (0.3-2.0%). There is little 
difference between the unsporulated and sporulated oocyst walls of E. tenella and E. maxima. 
Thus, the structure of proteins like EmGam56 is key to understanding how oocyst walls are 
constructed.
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Bioinformatic analyses indicated that EmGam56 is an intrinsically unstructured protein 
(IUP), dominated by random coils (52-70%), with some a-helices (28-43%) but few P-sheets 
(1-11%); this was confirmed by CD and 1D-NMR. Furthermore, the structural integrity of 
the protein under extreme temperatures (boiling for 40 minutes) and pH (pH 1.3-11) 
indicated its IUP nature. The intrinsic lack of structure in EmGam56 could facilitate its 
incorporation into the oocyst wall in two ways: first, IUPs are highly susceptible to 
proteolysis, explaining the several differently-sized oocyst wall proteins derived from 
EmGam56; and, second, the flexibility of IUPs could facilitate cross-linking between these 
tyrosine-rich derivatives.
Peroxidases are key to the formation of dityrosine bonds (see Belli et al, 2006 for a review). 
An in vitro cross-linking assay was developed using a recombinant 42 kDa truncation of 
EmGam56. The protein was exposed to various peroxidases and peroxides, the formation of 
polymers was followed by Western blotting, and the formation of dityrosines was determined 
by HPLC. Peroxidases from plants or fungi, but not mammals, catalysed rapid formation of 
polymers. No peroxidase has yet been found in the incompletely annotated E. tenella genome 
database but peroxidase activity has been detected in the wall forming bodies (Belli et al, 
2006). Therefore, future searches for Eimeria peroxidases should focus on plant-like 
homologous.
The results presented in this thesis support the proposal that dityrosine bonding between 
proteins is an important factor in the formation of the oocyst wall of coccidian parasites and 
are consistent with the hypothesis that antibodies stimulated by vaccination with EmGam56 
and related proteins could prevent formation of oocysts.
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